Pfiz­er sacks phar­ma com­pe­ti­tion in ear­ly NFL TV ad­ver­tis­ing sea­son

If phar­ma ad­ver­tis­ing had a fan­ta­sy foot­ball league, Pfiz­er would be crush­ing the com­pe­ti­tion. A dive in­to the Na­tion­al Foot­ball League’s TV com­mer­cial buys across ear­ly sea­son games by iS­pot shows a hefty lead with its Covid-19 Comir­naty vac­cine ads.

More than 175 mil­lion im­pres­sions with $9.5 mil­lion in me­dia spend­ing put Pfiz­er in the top spot with a 65% share of voice across NFL phar­ma spend­ing, ac­cord­ing to the re­al-time TV ad track­er. In a dis­tant sec­ond place is Bris­tol My­ers Squibb’s Op­di­vo with 44 mil­lion im­pres­sions, $5.2 mil­lion in spend­ing and a 16% share, fol­lowed by BMS’ Zeposia with 31 mil­lion im­pres­sions, $3.3 mil­lion in me­dia buys and an 11% share.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER